Introduction: 

Pharmacists in outpatient specialty, inpatient settings as well as retail pharmacies must stay informed about advanced treatments in lung cancer to provide optimal patient care. With the increased emergence of resistance offered by several mutations of tumor cells and influx of many modern targeted treatments and immunotherapies for lung cancer, it is crucial for these professionals to continuously educate themselves. This course provides a comprehensive guide covering most of the treatments indicated for the treatment of lung cancer. This course, along with others on our platform, aims to enhance the knowledge and skills of pharmacy professionals to address daily challenges and achieve job satisfaction.

Faculty:

Yogesh Gala, Rph, M.S., B.Pharm.

Pharmacy Manager, Health Systems Specialty Pharmacy, Walgreens at University of Miami, Miami, FL

Faculty Disclosure:

Yogesh Gala hereby states that he has no financial obligation or any commercial interest in any of the medicinal products discussed in this course. The peer reviewers too have no financial obligation or any commercial interest in any medicinal products discussed in this course. None of the people involved in creating this course have any affiliation with the pharmaceutical companies or manufacturers of any of the medications mentioned in this course.

Type of Activity: Knowledge-based and Application-based.

Continuing education credits: 4.0 hours

Media: Internet

Fees: $15

Estimated time to complete activity: 4 hours (It’s a self-paced online course. Participants can log out and log on anytime during the course. The progress of the course will be saved, and no work will be lost. The course needs to be completed within 3 months after which participants will lose access to the course.

 

Published date: May 4, 2025

Expires: May 3, 2028

Target Audience: Pharmacists

Eligibility Requirements:

Candidates must be Licensed Pharmacists. Their state licenses must be in good standing. Candidates do not need any other certification or credentials from any other company to take our courses.

Candidates do not need any pre-requisite courses or credentials to take this course. ProspeRx offers all courses to all Pharmacists and Pharmacy Technicians without any discrimination regarding race, religion, color, marital status, cultural background, ethnic origin, gender, socioeconomic or employment status.

How to Obtain Credit:

1. Register online to create an account and pay for the course.
2. Read the learning objectives and faculty disclosures.
3. Learn the course carefully and pay attention to the speaker’s tutoring. You may pause the slide as needed to fully understand the content.
4. The final exam consists of 20 questions. You will have 3 attempts to pass the final exam. The passing score is 70%.
5. Complete the final exam and post-activity evaluation right after the final exam within a maximum of 3 months of enrolling in the activity.

To answer the questions, click on your selected choice for each answer, then proceed to the next question. Once completed, click on the Grade Exam button at the bottom of the page. Your exam will be automatically graded. After you pass the exam and complete the post-test evaluation, your Certificate of completion will be made available immediately. Click on the Certificate of Completion link and print the certificate for your records. To receive credit, you must provide the day, month of the year and NABP eprofile ID number along with other required information in the registration process. All continuing education credits will be uploaded into the CPE monitor within 30 days.

PROSPERX will continue to update the course every 3 years from its inception in May 2025.

Goal:

This course aims to enhance the understanding of lung cancer pathophysiology, explore the latest advancements in lung cancer management, and study innovative treatments. Designed for pharmacists, it provides a comprehensive picture of all or most treatments involved in the treatment of lung cancer, determination of choice of treatments based on testing, and detailed discussion about these specialty medications while  equipping them with the knowledge to improve patient care through enhanced access to these treatment options.

Learning Objectives:

Upon completion of this course, participants will be able to learn and utilize these learnings towards patient care with better understanding with the following objectives:

• Describe lung cancer and its symptoms.
• Discuss types of Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).
• Describe staging in lung cancers.
• Understand mutations involved in lung cancers.
• Detail types of treatments for NSCLC.
• Describe individual drugs indicated for the treatment of NSCLC under Targeted therapies and Immunotherapies.
• Review currently approved indications, treatments guidelines, dosage, warnings/precautions and adverse effects.
• Describe individual drugs indicated for the treatment of SCLC.
• Formulate steps in patient care management.
• Discuss common side effects and their management.
• Discuss reimbursement process.
• Understand pharmacist’s role.

Software and Hardware requirements:

This course can be taken on any device enabled with basic internet capability. For the best experience, take the course on a PC, laptop or a MAC computer rather than smart phones or tablets. Both Operating systems, Windows 98 or higher and Macintosh 2.2 or higher are good to take our courses. Any standard Internet browser like Internet Explorer 6.0 or higher, Microsoft Edge, Safari 5.0.6 or higher, Google Chrome, Firefox 3.0.3 or higher, etc. should work for this online course.

Disclosure of Unlabeled Use and Disclaimer:

All information about medications, indications, dosing, side effects, administration and other clinical/scientific information is current as of the date of release of this course. ProspeRx has made all reasonable efforts to ensure that the information presented is accurate as per the latest scientific/clinical information available at the time of publishing this course. However, there is continuous research and developments happening in the pharmaceutical industry leading to changes in treatments and criteria. Participants are therefore advised to check the current FDA guidelines and/or manufacturer’s specifications while dealing with these medications and treatments.

Faculty has added his personal experience and instructional content-both written and verbal that is not evaluated by FDA. These instructions are meant to guide the participants to better perform their job functions but are not meant to override their current operational practices. Participants are advised to refer to the best practices of their own employers/institutions to comply with their operational policies and procedures. 

Our courses are strictly meant for educational purposes only. Currently, ProspeRx is only approved as a CE provider by the Florida and Michigan Boards of Pharmacy and therefore, you will receive continuing education credits only if you are a Florida or Michigan pharmacy practitioner.